Literature DB >> 30587577

Dephosphorylation of human dopamine transporter at threonine 48 by protein phosphatase PP1/2A up-regulates transport velocity.

Jae-Won Yang1, Garret Larson2, Lisa Konrad1, Madhur Shetty2, Marion Holy1, Kathrin Jäntsch1, Mirja Kastein1, Seok Heo3, Fatma Asli Erdem1, Gert Lubec4, Roxanne A Vaughan2, Harald H Sitte5, James D Foster6.   

Abstract

Several protein kinases, including protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and extracellular signal-regulated kinase, play key roles in the regulation of dopamine transporter (DAT) functions. These functions include surface expression, internalization, and forward and reverse transport, with phosphorylation sites for these kinases being linked to distinct regions of the DAT N terminus. Protein phosphatases (PPs) also regulate DAT activity, but the specific residues associated with their activities have not yet been elucidated. In this study, using co-immunoprecipitation followed by MS and immunoblotting analyses, we demonstrate the association of DAT with PP1 and PP2A in the mouse brain and heterologous cell systems. By applying MS in conjunction with a metabolic labeling method, we defined a PP1/2A-sensitive phosphorylation site at Thr-48 in human DAT, a residue that has not been previously reported to be involved in DAT phosphorylation. Site-directed mutagenesis of Thr-48 to Ala (T48A) to prevent phosphorylation enhanced dopamine transport kinetics, supporting a role for this residue in regulating DAT activity. Moreover, T48A-DAT displayed increased palmitoylation, suggesting that phosphorylation/dephosphorylation at this site has an additional regulatory role and reinforcing a previously reported reciprocal relationship between C-terminal palmitoylation and N-terminal phosphorylation.
© 2019 Yang et al.

Entities:  

Keywords:  dephosphorylation; dopamine transporter; mass spectrometry (MS); neurotransmission; okadaic acid; palmitoylation; phosphorylation; post-translational modification (PTM); protein phosphatase; protein-protein interaction; synaptic transmission

Mesh:

Substances:

Year:  2018        PMID: 30587577      PMCID: PMC6416449          DOI: 10.1074/jbc.RA118.005251

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A.

Authors:  A L Bauman; S Apparsundaram; S Ramamoorthy; B E Wadzinski; R A Vaughan; R D Blakely
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.

Authors:  Uhna Sung; Jennifer L Jennings; Andrew J Link; Randy D Blakely
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

3.  Targeted gene expression in dopamine and serotonin neurons of the mouse brain.

Authors:  Xiaoxi Zhuang; Justine Masson; Jay A Gingrich; Stephen Rayport; René Hen
Journal:  J Neurosci Methods       Date:  2004-11-24       Impact factor: 2.390

4.  Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

Authors:  James D Foster; Benchaporn Pananusorn; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

5.  Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation.

Authors:  James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

6.  Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.

Authors:  B J Copeland; V Vogelsberg; N H Neff; M Hadjiconstantinou
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

7.  Regulation of the functional activity of the human dopamine transporter by protein kinase C.

Authors:  L Zhang; L L Coffey; M E Reith
Journal:  Biochem Pharmacol       Date:  1997-03-07       Impact factor: 5.858

8.  Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.

Authors:  D Sulzer; T K Chen; Y Y Lau; H Kristensen; S Rayport; A Ewing
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 9.  Mechanisms of dopamine transporter regulation in normal and disease states.

Authors:  Roxanne A Vaughan; James D Foster
Journal:  Trends Pharmacol Sci       Date:  2013-08-20       Impact factor: 14.819

10.  Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens.

Authors:  Devadoss J Samuvel; Lankupalle D Jayanthi; Senthilvelan Manohar; Kolanjiappan Kaliyaperumal; Ronald E See; Sammanda Ramamoorthy
Journal:  J Pharmacol Exp Ther       Date:  2008-01-15       Impact factor: 4.030

View more
  5 in total

1.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

Review 2.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

3.  Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.

Authors:  Ulrika H Julku; Maria Jäntti; Reinis Svarcbahs; Timo T Myöhänen
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

4.  Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

Authors:  Huriye Ercan; Waltraud Cornelia Schrottmaier; Anita Pirabe; Anna Schmuckenschlager; David Pereyra; Jonas Santol; Erich Pawelka; Marianna T Traugott; Christian Schörgenhofer; Tamara Seitz; Mario Karolyi; Jae-Won Yang; Bernd Jilma; Alexander Zoufaly; Alice Assinger; Maria Zellner
Journal:  Front Cardiovasc Med       Date:  2021-11-11

5.  Constitutive Endocytosis of the Neuronal Glutamate Transporter Excitatory Amino Acid Transporter-3 Requires ARFGAP1.

Authors:  Kusumika Saha; Jae-Won Yang; Tina Hofmaier; SanthoshKannan Venkatesan; Thomas Steinkellner; Oliver Kudlacek; Sonja Sucic; Michael Freissmuth; Harald H Sitte
Journal:  Front Physiol       Date:  2021-05-10       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.